Zhone Technologies, Inc. (NASDAQ: ZHNE) has introduced the 2101P GPON Optical Network Terminal (ONT), its first single-port ONT with Power Over Ethernet (PoE) designed for industrial and...

The 24th China (Shenzhen) International Gifts and Home Products Fair is scheduled to be held from October 20 to 23, 2016, at Shenzhen Convention & Exhibition Center. As China's largest gifts trade...

Smith Micro Software, Inc. (NASDAQ: SMSI), today announced that William W. Smith, Jr., president and CEO, will be presenting at the Rodman & Renshaw 18th Annual Global Investment Conference on...

Boehringer Ingelheim Pharmaceuticals, Inc. presented eight idiopathic pulmonary fibrosis (IPF)-related abstracts at the European Respiratory Society (ERS) International Congress 2016, including...

Halyard Health, Inc. (NYSE: HYH) today announced that Robert Abernathy, chairman and chief executive officer, will present at the Morgan Stanley Global Healthcare Conference at the Grand Hyatt...

IBC Expo, Amsterdam - September 7th, 2016 - ALi Corporation, a leading Set-Top Box (STB) chipset provider, today announced that it has further extended its partnership with security partner Conax, a leader in total content and service protection for digital entertainment services.

Oslo, September 7th, 2016: Conax, part of the Kudelski Group (SIX:KUD:S), and a leader in total service protection for digital entertainment services worldwide via broadcast, broadband and connected devices, today announced pay-TV operator Cignal TV is deploying Conax Cardless content protection technology to secure the next phases of growth.

VIVA Physicians, a not-for-profit organization dedicated to advancing the field of vascular medicine and intervention through education and research, is excited to announce the late-breaking...

RXi Pharmaceuticals Corporation (NASDAQ: RXII), a clinical-stage RNAi company developing innovative therapeutics that address significant unmet medical needs, announced today it has been selected...

Viking Therapeutics, Inc. ("Viking") (NASDAQ: VKTX), a clinical-stage biopharmaceutical company focused on the development of novel therapies for metabolic and endocrine disorders, today announced...